ChangePartners
VC Fund
Porto, Portugal
ChangePartners is an independent company dedicated to mid-size transactions in the Iberian market. They develop high value added solutions specific to each particular situation , offering a fair and unbiased opinion. Their independence guarantees no conflicts of interest. Their small size and focus ensures full dedication to each transaction.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries ChangePartners invests in
Stages ChangePartners invests in
Countries ChangePartners invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Medical 2 (100%)
- Biotechnology 2 (100%)
- Life Science 1 (50%)
- Therapeutics 1 (50%)
- Medical Device 1 (50%)
Stage
- Seed 1 (50%)
- Series A 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Mário Pinto
Founder and Member of the Board of Directors
|
Founder and Member of the Board of Directors | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Exogenus Therapeutics is engineering cell biology for innovative therapeutic solutions.Exo-T is a biotechnology company dedicated to the pre-clinical and clinical development of innovative cellular-based therapies applied to regenerative medicine, specifically for the skin lesions treatment. The company is presently developing its first product,Exo-Wound, for the treatment of chronic wounds.The project that led to the creation of the company (Nanoinspire) participated in COHiTEC 2014 program and is the result of the research developed in collaboration with Crioestaminal SA, Biocant, and Centre for Neurosciences and Cellular Biology of Coimbra University. | $870.5K / Seed / Dec 04, 2015 | ||
| Biomode is a startup venture based in Caldas das Taipas (Portugal) that aims to be a leading provider of rapid and accurate molecular diagnostic tests for identification of pathogens in the food, environment and life science industries.Biomode’s diagnostic kits are based on the PNA-FISH (Peptide Nucleic Acid Fluorescence In Situ Hybridisation)technology.Biomode’s founders are a group of researchers from the universities of Minho and Porto (Portugal) that is one of the few worldwide research groups with the skills to design PNA-FISH probes targeting specific pathogens.Biomode will enter the food industry diagnostics market with a kit for detecting Salmonella in food samples (Probe4Salmonella®) soon to be followed by two other kits for the detection of Listeria monocytogenes and E. coli O157:H7. On the clinical diagnostics area, Biomode has already developed a kit aimed at the rapid identification of clarithromycin resistance of H. Pylori strains (Probe4Pylori®) that is in the process of obtaining investigational device exemption from the Food and Drug Administration (FDA) in order to undergo field trials. | $1.7M / Series A / Mar 19, 2015 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does ChangePartners invest in?
ChangePartners invests primarily in Medical, Biotechnology and Life Science startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in Portugal. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact ChangePartners?
Public channels for ChangePartners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at ChangePartners?
The team at ChangePartners includes Mário Pinto (Founder and Member of the Board of Directors). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
